It would also be of interest to evaluate whether ColQ or LRP4 identified mutations or autoantibodies, responsible for congenital myasthenia or myasthenia gravis, disrupt or diminish the interaction between LRP4 and ColQ. This evidence concerns the gene COLQ and congenital myasthenic syndrome.